Clinical Team
Company Profile
Careers
News
Contact Us
Sign In
Search
Oncofocus
Immunofocus PD-L1 Test
About Us
Contact Us
Request a Test
Oncofocus Cancer Test
The Oncofocus test for cancer
Technical Overview
Sample test reports
Immunotherapy Cancer Tests
What is Immunotherapy?
Immunofocus TMB Test
Immunofocus PD-L1 Test
Research & Diagnostic services
R&D
Contract Research
Precision Oncology
Molecular Pathology Diagnostics
Cdc7 Onco Checkpoint™
Testimonials
Request a Test
Category Archive: Therapies
Home
FDA approved therapies
Genomics and cancer treatment: new events will showcase developments
‘Most exciting cancer treatment since chemotherapy’ could save patients using DNA tests
‘New era’ of personalised cancer drugs, say doctors
‘Revolutionary’ new class of cancer drugs approved
4th Quality & Innovation Meeting – Pancreatic Disorders
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
A novel p53-Cdc7 link induced by genotoxic stress
Abarelix for injectable suspension
Abiraterone acetate
Ado-trastuzumab emtansine
Adrenocortical carcinoma
Afatinib
Alectinib
Alfuzosin Hydrochloride
AML and chemotherapy. A study recently co-authored by Oncologica
Anal cancer
Anaplastic astrocytoma
Aprepitant
Axitinib
Basal-cell carcinoma
Bevacizumab
Bevacizumab
Bevacizumab
Binimetinib Improves PFS in NRAS-mutant Melanoma
Bladder cancer
Bone tumour
Bortezomib
Brain Tumor
Brainstem glioma
Breast Cancer
Cabazitaxel
Cabozantinib
Cancer Conferences Participation. June 2019
Cancer immunotherapy drug “less toxic and prolongs life”
Cancer treatment untested in many patients with immune problems
Capecitabine
Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint
Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment
Ceritinib
Cervical cancer
Cervical intraepithelial neoplasia
Cetuximab
Chemotherapy is no longer the only option against cancer…
Cholangiocarcinoma
Cinacalcet
Cobimetinib
Colorectal cancer
Coming ever closer – first PARP inhibitor licensed in Europe
Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer
Conjugated estrogens
Consensus on genomic classification of bladder cancer makes progress
Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay
Crizotinib
Dabrafenib
Dad with terminal cancer given hope by ground-breaking precision oncology test
Defining cancers based on genetic ‘fingerprint’ could help personalise treatment
Degarelix for injection
Denosumab
Denosumab
Dinutuximab
DNA ‘barcode’ delivering personalised breast cancer care
Docetaxel
Doxorubicin HCl liposome injection
Efficacy of Osimertinib in Advanced T790M-positive NSCLC
Endometrial cancer
Enzalutamide
Epirubicin hydrochloride
Eribulin mesylate
Erlotinib
Esophageal cancer
Everolimus
Everolimus
Everolimus
Everolimus
Every cancer patient could have DNA tested under five-year government plan to cut deaths
Every child with cancer to have tumour DNA sequenced to find best treatment
Ewing’s sarcoma
Exemestane
Fallopian tube cancer
FDA Approves First Immunotherapy for Breast Cancer
Fentanyl buccal
Fentanyl citrate
Fentanyl sublingual spray
Fentanyl sublingual tablets
Ferumoxides
Frontline Pembrolizumab Combo Approved by FDA for NSCLC
Fulvestrant
Gallbladder cancer
Gastric cancer
Gefitinib
Gemcitabine HCL
Genetic testing of tumours could personalise cancer treatment, experts say
Genomic Profiling in Sarcoma Shows Potential in Guiding Clinical Management
Germ cell tumor
Giant-cell tumor of bone
GIST
Glioblastoma
Goserelin acetate implant
Granisetron
Granisetron
Groundbreaking discovery made use skin cells to kill cancer
Human Papillomavirus Bivalent
Hypopharyngeal cancer
Ibritumomab tiuxetan
Imatinib and GISTs: Genomic Subtypes and Survival Outcomes
Imatinib mesylate
Imiquimod
Immunotherapy offers hope for men with prostate cancer
Immunotherapy, Molecular Testing Propel Dramatic Changes in Lung Cancer Care
Immunotherapy: new hope in the battle against cancer
Improving Patient Education and Access: How Can We Better Leverage Advances in Cancer Diagnostics and Treatment
Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in Non-Small-Cell-Lung Cancer (NSCLC)
Iodixanol
Ipilimumab
Irinotecan liposome injection
Ixabepilone
Kaposi’s sarcoma
Kidney cancer
Lapatinib
Laryngeal cancer
Leiomyosarcoma
Lenvatinib
Letrozole
Leuprolide acetate
Leuprolide Acetate
Levoleucovorin
Liposarcoma
Liver cancer
Lung Cancer
Lung Cancer Driver Discovery May Lead to Novel Therapy for Some Mesothelioma Patients
Malignant rhabdoid tumour
Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies
Mechlorethamine
Melanoma
Merkel-cell carcinoma
Mesothelioma
Mesothelioma shows promising response to existing immunotherapy drug
Model shows cancer’s birth and spread from single cell
Mutation-Targeted Therapy Slows Lung Cancer (NSCLC)
Mutations Matter: Cholangiocarcinoma Tumor Profiling Awareness
Mycosis fungoides
Nasopharynx cancer
Necitumumab
Neuroblastoma
New biomarker identifies uveal melanoma patients at high risk for metastasis
New Insights Into Rucaparib Activity in Ovarian Cancer
NHS should give all cancer patients personalised care
NICE says yes to Novartis’ Afinitor in kidney cancer
Nivolumab
Nivolumab
Nobel prize for medicine goes to cancer therapy
Olaparib
Olaratumab May Improve Disease Control in Certain Patients With GIST
OncoCheckpoint: Companion DX for Cdc7 inhibitors
Oncofocus a revolutionary test that can tailor the best therapy for cancer patients
Oncofocus Cancer Test and targeted therapies. The Revolution in cancer treatment has begun.
Oncofocus Cancer Test is now covered by all leading health insurers
Oncologica live on The Pat Kenny Show – IRELAND
Oncologica Ltd. to open lab in Dublin
Oncologica UK contributes to setting new guidelines for implementation of Next Generation Sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours. An expert opinion on behalf of IQN Path ASBL.
Ondansetron oral soluble film
Oropharyngeal cancer
Osimertinib
Osteosarcoma
Ovarian Cancer
Oxaliplatin
p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress.
Paclitaxel
Paclitaxel protein-bound particles for injectable suspension
Palbociclib
Palonosetron
Pancreatic cancer
Pancreatic cancer found to be four separate diseases
Pancreatic neuroendocrine tumors
Panitumumab
Paraganglioma
Parathyroid carcinoma
PAT KENNY SHOW talk available as podcast
Pazopanib
Pazopanib
Pegfilgrastim
Peginterferon alfa-2b
Pembrolizumab
Pemetrexed
Pemetrexed for injection
Penile cancer
Pertuzumab
Petupitant and palonosetron
Pheochromocytoma
Pityriasis lichenoides et varioliformis acuta
Pleuropulmonary blastoma
Pralatrexate
Precision medicine can widen cancer care options, studies find
Precision medicine demonstrates benefit in late-stage cancer trial
Precision Medicine is hot topic at ASCO
Precision medicine the theme at world’s biggest cancer conference
Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs
Prof U. Tirelli: The best cure against cancer is a test
Prostate cancer
Quadrivalent human papillomavirus
Radium Ra 223 dichloride
Raloxifene hydrochloride
Ramucirumab
Rasburicase
Regorafenib
Regorafenib
Renal cell carcinoma
Retinoblastoma
Revolutionary test can tailor the best therapy for cancer patients
Rhabdomyosarcoma
Rolapitant
Romidepsin
Sardinia has chosen the Oncofocus test for its patients
Secretin
Sézary disease
Sherrie Hewson’s brother diagnosed with an “incurable” brain tumour now enlisted the help of a special medical company called Oncologica
Sipuleucel-T
Skin cancer
Soft-tissue sarcoma
Sonidegib
Sorafenib
Sorafenib
Sunitinib
Sunitinib malate
Taking the Oncofocus Test: Karan’s Testimony
Talimogene laherparepvec
Targeted cancer care to spare thousands of patients chemotherapy
Tbo-filgrastim
Temozolomide
Temsirolimus
Testicular cancer
The cancer revolution: Personalised treatment that’s ‘six times better’ than traditional methods at beating the disease
The most precise treatments with genetic tests
THE ONCOFOCUS TEST
The personalisation of cancer treatments is leading to better outcomes for patients
The Testimony of an Oncofocus Patient
There’s a real sense of optimism around new ways of tackling lung cancer
Thousands of Pounds Raised for Mother of Five’s Cancer Treatment
Thymoma
Thyroid cancer
Topotecan hydrochloride
Topotecan hydrochloride
Tositumomab
Trabectedin
Trametinib
Trastuzumab
Trifluridine and tipiracil
Triptorelin pamoate
Tucatinib (ONT-380) progressing in pivotal trial against HER2+ breast cancer
Two combination therapies shrink melanoma brain metastases in more than half of patients
UK chief medical officer calls for gene testing revolution within five years. But the revolution is actually already here.
Using Tumor Genomic Profiling to Guide Treatment Selection Extends Survival in Advanced Sarcoma
Uveal melanoma
Vaginal cancer
Vandetanib
Vemurafenib
Vismodegib
Vulvar cancer
What does personalised medicine mean for you?
Wilms’ tumour
World Cancer Day 2017
Ziv-aflibercept
Zoledronic acid
Zoledronic acid